COMMUNIQUÉS West-GlobeNewswire

Biocartis Group NV: Disclosure of outstanding voting securities
21/12/2018
PRESS RELEASE : REGULATED INFORMATION 21 December 2018, 07:00 CET Disclosure of Outstanding Voting Securities Mechelen, Belgium, 21 December 2018 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative [...]
CROSSJECT : SUCCES DE L'AUGMENTATION DE CAPITAL D'UN MONTANT DE 4 MILLIONS D'EUROS
21/12/2018
Communiqué de Presse SUCCES DE L'AUGMENTATION DE CAPITAL D'UN MONTANT DE 4 MILLIONS D'EUROS Opération intégralement souscrite Règlement livraison des actions nouvelles le 28 décembre 2018 Dijon, le 21 décembre 2018 [...]
ObsEva SA Announces Completion of Patient Recruitment in PRIMROSE 2 Phase 3 Clinical Trial of Linzagolix for the Treatment of Heavy Menstrual Bleeding Associated with Uterine Fibroids
21/12/2018
Geneva, Switzerland and Boston, MA – December 21, 2018 – ObsEva SA (NASDAQ: OBSV), a clinical- stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
IBA to install a proton therapy solution in Charleroi, Belgium, and Dosimetry update
21/12/2018
IBA receives purchase order to install its Proteus ® ONE compact proton therapy solution in Charleroi Strategic review of Dosimetry division ongoing Louvain-La-Neuve, Belgium, 21 December 2018 - IBA (Ion Beam [...]
IBA installera une solution de protonthérapie à Charleroi, Belgique, et informe sur son activité Dosimétrie
21/12/2018
IBA a reçu le bon de commande pour installer sa solution compacte de protonthérapie Proteus ® ONE à Charleroi La revue stratégique de la division Dosimétrie est toujours en cours Louvain-la-Neuve, Belgique, 21 décembre [...]
PLx Pharma Inc. Announces $15 Million Convertible Preferred Stock Financing
21/12/2018
HOUSTON, Dec. 20, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Vazalore™ 325 [...]
Guardant Health to Present at the 37th Annual J.P. Morgan Healthcare Conference
21/12/2018
REDWOOD CITY, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast [...]
Veritas Appoints Corporate Secretary & CFO; and Issues Stock Options
21/12/2018
VANCOUVER, British Columbia, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce the appointment of Blair Lowther as [...]
Genetic Technologies Limited Announces New Biomedical Blockchain Joint Venture
21/12/2018
MELBOURNE, Australia, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), via its subsidiary Gene Ventures Pty Ltd, is pleased to announce that it has entered into a joint [...]
President Signs Farm Bill, Hemp Legalization to Impact New Mexico
20/12/2018
Ultra Health gains two licenses to cultivate low-THC varieties of cannabis ALBUQUERQUE, N.M., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Ultra Health, New Mexico’s #1 Cannabis Company with a nationwide presence, has expanded its [...]
Zomedica Provides Update on Pipeline Development and Announces At-The-Market Offering Program
20/12/2018
ANN ARBOR, Mich., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today provided an update on its pipeline [...]
Akorn Names Douglas S. Boothe as President and CEO
20/12/2018
LAKE FOREST, Ill., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (NASDAQ: AKRX), today announced that Douglas S. Boothe has been named president and chief executive officer effective January 1, 2019, bringing deep [...]
Helix BioPharma Corp. Closes Second Tranche of Private Placement
20/12/2018
RICHMOND HILL, Ontario, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2018
20/12/2018
BEIJING, Dec. 20, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced [...]
ContraFect to Present at Biotech Showcase 2019
20/12/2018
YONKERS, N.Y., Dec. 20, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]
Viveve Announces FDA Clearance to Advance VIVEVE II Clinical Study to Full Enrollment
20/12/2018
- Sites to continue enrollment up to 250 patients in sexual function trial - ENGLEWOOD, Colo., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's [...]
Merus Announces Global Settlement and End to All Patent Litigation with Regeneron Pharmaceuticals
20/12/2018
Merus and Regeneron to cross-license patents relating to certain antibody generation platform technologies Regeneron to purchase $15 million of Merus common shares UTRECHT, The Netherlands, Dec. 20, 2018 (GLOBE NEWSWIRE [...]
Imagin Medical Reports Fiscal Year End 2018 Results
20/12/2018
VANCOUVER, British Columbia and BOSTON, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results [...]
Dova Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/12/2018
DURHAM, N.C., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (Nasdaq: DOVA), a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for diseases where there is a [...]

Pages